DOM-1516

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDOM-1516
Drug Alias Namedual-targeting dAb thearpy (Domantis)domain antibody therapy (Domantis)DOM-1516
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionGrowth factor receptors antagonists
TargetsGrowth factor receptors
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDomantis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDomantis Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A